Gallagher ML. The nutrients and their metabolism. In: Mahan LK, Escott-Stump S, eds. Krause's food & nutrition therapy. 12th ed. St. Louis, MO: Elsevier; 2008:86-88.
Kirkland JB, Rawley JM. Niacin. In: Bucker RB, Suttie JW, McCormick DB, et al, eds. Handbook of vitamins. 3rd ed. Basel, Switzerland: Marcel Dekker, Inc; 2001:213-254.
Ishii N, Nishihara Y. Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy. J Neurol Neurosurg Psychiatry. 1985;48:628-634.
Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol. 2005;6:165-173.
World Health Organization. The management of nutrition in major emergencies. 2000. http://www.who.int/ (last accessed 1 September 2017).
MacDonald A, Forsyth A. Nutritional deficiencies and the skin. Clin Exp Dermatol. 2005;30:388-390.
Institute of Medicine. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, pantothenic acid, biotin and choline. Washington, DC: Food and Nutrition Board, National Academy Press; 1998.
Machlin LJ, Hüni JE. Vitamins basics. Basel, Switzerland: F. Hoffmann-La Roche Ltd; 1994:41-48.
Serdaru M, Hausser-Hauw C, Laplane D, et al. The clinical spectrum of alcoholic pellagra encephalopathy: a retrospective analysis of 22 cases studied pathologically. Brain. 1988;111:829-842.
Sauberlich HE. Laboratory tests for the assessment of nutritional status. 2nd ed. Boca Raton, FL: CRC Press; 1999:161-174.
1. Gallagher ML. The nutrients and their metabolism. In: Mahan LK, Escott-Stump S, eds. Krause's food & nutrition therapy. 12th ed. St. Louis, MO: Elsevier; 2008:86-88.
2. Jacob RA. Niacin. In: Bowman BA, Russell RM, eds. Present knowledge in nutrition. 8th ed. Washington, DC: ILSI Press; 2001:199-206.
3. WHO/FAO. Vitamin and mineral requirements in human nutrition. Report of a joint FAO/WHO expert consultation. Bangkok, Thailand. Rome. 2004.
4. Kirkland JB, Rawley JM. Niacin. In: Bucker RB, Suttie JW, McCormick DB, et al, eds. Handbook of vitamins. 3rd ed. Basel, Switzerland: Marcel Dekker, Inc; 2001:213-254.
5. Ghosh A, Pallavi SK, Nagpal B, et al. Role of vitamins in oral health & disease: an overview. Indian J Applied Res. 2015;5:5292-295.
6. Schellack B, Harirari P, Schellack N. B-complex vitamin deficiency and supplementation. S Afr Pharm J. 2016;83:14-19.
7. Ishii N, Nishihara Y. Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy. J Neurol Neurosurg Psychiatry. 1985;48:628-634.
8. Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol. 2005;6:165-173.
9. Prousky JE. Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature. Altern Med Rev. 2003;8:180-185.
10. Hegyi J, Schwartz RA, Hegyi V. Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol. 2004;43:1-5.
11. Darvay A, Basarab T, McGregor JM, et al. Isoniazid induced pellagra despite pyridoxine supplementation. Clin Exp Dermatol. 1999;24:167-169.
12. Martínez-Coronado J, Torres-Alvarez B, Castanedo-Cázares JP. Goose skin in a girl with Ehlers-Danlos syndrome. J Community Hosp Intern Med Perspect. 2015;5:28216.
13. World Health Organization. The management of nutrition in major emergencies. 2000. http://www.who.int/ (last accessed 1 September 2017).
14. Chawla J, Kvarnberg D. Hydrosoluble vitamins. Handb Clin Neurol. 2014;120:891-914.
15. Park YK, Sempos CT, Barton CN, et al. Effectiveness of food fortification in the United States: the case of pellagra. Am J Public Health. 2000;90:727-738.
17. Seal AJ, Creeke PI, Dibari F, et al. Low and deficient niacin status and pellagra are endemic in postwar Angola. Am J Clin Nutr. 2007;85:218-224.
18. Lee BY, Thurmon TF. Nutritional disorders among workers in North China during national turmoil. Ann Nutr Metab. 2001;45:175-180.
19. Malfait P, Moren A, Dillon JC, et al. An outbreak of pellagra related to changes in dietary niacin among Mozambican refugees in Malawi. Int J Epidemiol. 1993;22:504-511.
20. Pipili C, Cholongitas E, Ioannidou D. The diagnostic importance of photosensitivity dermatoses in chronic alcoholism: report of two cases. Dermatol Online J. 2008;14:15.
21. Kertesz SG. Pellagra in 2 homeless men. Mayo Clin Proc. 2001;76:315-318.
22. Viljoen M, Swanepoel A, Bipath P. Antidepressants may lead to a decrease in niacin and NAD in patients with poor dietary intake. Med Hypotheses. 2015;84:178-182.
23. Jagielska G, Tomaszewicz-Libudzic EC, et al. Pellagra: a rare complication of anorexia nervosa. Eur Child Adolesc Psychiatry. 2007;16:417-420.
24. Ballmer-Weber BK, Braathen LR, Ballmer PE. Erythema following malnutrition and exposure to sunlight [in German]. Schweiz Med Wochenschr. 1999;129:1492-1495.
25. Judd LE, Poskitt BL. Pellagra in a patient with an eating disorder. Br J Dermatol. 1991;125:71-72.
26. Rapaport MJ. Pellagra in a patient with anorexia nervosa. Arch Dermatol. 1985;121:255-257.
27. MacDonald A, Forsyth A. Nutritional deficiencies and the skin. Clin Exp Dermatol. 2005;30:388-390.
28. Pollack S, Enat R, Haim S, et al. Pellagra as the presenting manifestation of Crohn's disease. Gastroenterology. 1982;82:948-952.
29. Abu-Qurshin R, Naschitz JE, Zuckermann E, et al. Crohn's disease associated with pellagra and increased excretion of 5-hydroxyindolacetic acid. Am J Med Sci. 1997;313:111-113.
30. Zaki I, Millard L. Pellagra complicating Crohn's disease. Postgrad Med J. 1995;71:496-497.
31. Sanderson IR. Unusual colitides. Baillieres Clin Gastroenterol. 1994;8:181-196.
32. Varella Morandi Junqueira-Franco M, Ernesto Troncon L, Garcia Chiarello P, et al. Intestinal permeability and oxidative stress in patients with alcoholic pellagra. Clin Nutr. 2006;25:977-983.
33. Greenberg DM, Lee JW. Psychotic manifestations of alcoholism. Curr Psychiatry Rep. 2001;3:314-318.
34. Cook CC, Hallwood PM, Thomson AD. B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol. 1998;33:317-336.
35. Ishii N, Nishihara Y. Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases. J Neurol Neurosurg Psychiatry. 1981;44:209-215.
36. Victor M. Persistent altered mentation due to ethanol. Neurol Clin. 1993;11:639-661.
37. Badawy AA. Pellagra and alcoholism: a biochemical perspective. Alcohol Alcohol. 2014;49:238-250.
38. Institute of Medicine. Dietary reference intakes for thiamine, riboflavin, niacin, vitamin B6, pantothenic acid, biotin and choline. Washington, DC: Food and Nutrition Board, National Academy Press; 1998.
39. Rose DP, Braidman IP. Excretion of tryptophan metabolites as affected by pregnancy, contraceptive steroids, and steroid hormones. Am J Clin Nutr. 1971;24:673-683.
40. van der Horst-Schrivers AN, Wymenga AN, Links TP, et al. Complications of midgut carcinoid tumors and carcinoid syndrome. Neuroendocrinology. 2004;80(suppl 1):S28-S32.
41. Shah GM, Shah RG, Veillette H, et al. Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am J Gastroenterol. 2005;100:2307-2314.
42. Murray MF, Nghiem M, Srinivasan A. HIV infection decreases intracellular nicotinamide adenine dinucleotide (NAD). Biochem Biophys Res Commun. 1995;212:126-131.
43. Murray MF. Niacin as a potential AIDS preventive factor. Med Hypotheses. 1999;53:375-379.
44. Tremeschin MH, Cervi MC, Camelo Júnior JS, et al. Niacin nutritional status in HIV type 1-positive children: preliminary data. J Pediatr Gastroenterol Nutr. 2007;44:629-633.
45. Machlin LJ, Hüni JE. Vitamins basics. Basel, Switzerland: F. Hoffmann-La Roche Ltd; 1994:41-48.
46. György P. Developments leading to the metabolic role of vitamin B 6. Am J Clin Nutr. 1971;24:1250-1256.
47. Carpenter KJ, Lewin WJ. A reexamination of the composition of diets associated with pellagra. J Nutr. 1985;115:543-552.
48. Pitche PT. Pellagra [in French]. Sante. 2005;15:205-208.
49. Muratake T, Watanabe H, Hayashi S. Isoniazid-induced pellagra and the N-acetyltransferase gene genotype. Am J Psychiatry. 1999;156:660.
50. Harrington CI. A case of pellagra induced by isoniazid therapy. Practitioner. 1977;218:716-717.
51. Holdiness MR. Adverse cutaneous reactions to antituberculosis drugs. Int J Dermatol. 1985;24:280-285.
52. Bipath P, Levay PF, Viljoen M. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population. BMC Infect Dis. 2015;15:346.
53. Pereira FB, Miraglia F, Schmitz CB, et al. The most significant deficiencies in macro and micro nutrients in adolescents living with HIV/AIDS in antiretroviral therapy. Nutr Hosp. 2016;33:21-25.
54. Akerele D. Household food expenditure patterns, food nutrient consumption and nutritional vulnerability in Nigeria: implications for policy. Ecol Food Nutr. 2015;54:546-571.
55. Serdaru M, Hausser-Hauw C, Laplane D, et al. The clinical spectrum of alcoholic pellagra encephalopathy: a retrospective analysis of 22 cases studied pathologically. Brain. 1988;111:829-842.
56. Hauw JJ, De Baecque C, Hausser-Hauw C, et al. Chromatolysis in alcoholic encephalopathies: pellagra-like changes in 22 cases. Brain. 1988;111:843-857.
57. Mirahmadian M, Motahareh H, Taheri E, et al. The short-term influence of gastric bypass surgery on dietary intakes in morbidly obese patients. J Nutr Sci Dietetics 2015.1:134-140.
58. Tyler I, Wiseman MC, Crawford RI, et al. Cutaneous manifestations of eating disorders. J Cutan Med Surg. 2002;6:345-353.
59. Bröer S, Cavanaugh JA, Rasko JE. Neutral amino acid transport in epithelial cells and its malfunction in Hartnup disorder. Biochem Soc Trans. 2005;33:233-236.
60. Kleta R, Romeo E, Ristic Z, et al. Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet. 2004;36:999-1002.
61. Milovanović D, Djukić A, Stepanović R, et al. Hartnup disease: report of 2 cases in one family [in Serbian]. Srp Arh Celok Lek. 2000;128:97-103.
62. Oakley A, Wallace J. Hartnup disease presenting in an adult. Clin Exp Dermatol. 1994;19:407-408.
63. Freundlich E, Statter M, Yatziv S. Familial pellagra-like skin rash with neurological manifestations. Arch Dis Child. 1981;56:146-148.
64. Bell HK, Poston GJ, Vora J, et al. Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol. 2005;152:71-75.
65. Vinik A, Moattari AR. Use of somatostatin analog in management of carcinoid syndrome. Dig Dis Sci. 1989;34(3 suppl):14S-27S.
66. Reichman O, Sobel JD. Vulvovaginal pellagra and lichen sclerosus complicating carcinoid syndrome. Obstet Gynecol. 2009;113:543-545.
67. Swain CP, Tavill AS, Neale G. Studies of tryptophan and albumin metabolism in a patient with carcinoid syndrome, pellagra, and hypoproteinemia. Gastroenterology. 1976;71:484-489.
68. Krishnamachari KA. Some aspects of copper metabolism in pellagra. Am J Clin Nutr. 1974;27:108-111.
69. Oduho GW, Han Y, Baker DH. Iron deficiency reduces the efficacy of tryptophan as a niacin precursor. J Nutr. 1994;124:444-450.
70. Park YH, de Groot LC, van Staveren WA. Dietary intake and anthropometry of Korean elderly people: a literature review. Asia Pac J Clin Nutr. 2003;12:234-242.
71. Woo J, Kwok T, Ho SC, et al. Nutritional status of elderly Chinese vegetarians. Age Ageing. 1998;27:455-461.
72. Russell RM. The aging process as a modifier of metabolism. Am J Clin Nutr. 2000;72(2 suppl):529S-532S.
73. Mponda K, Masenga J. Skin diseases among elderly patients attending skin clinic at the Regional Dermatology Training Centre, Northern Tanzania: a cross-sectional study. BMC Res Notes. 2016;9:119.
74. Balk E, Chung M, Raman G, et al. B vitamins and berries and age-related neurodegenerative disorders. Evid Rep Technol Assess (Full Rep). 2006;134:1-161.
75. Morris MC, Schneider JA, Tangney CC. Thoughts on B-vitamins and dementia. J Alzheimers Dis. 2006;9:429-433.
76. Semba RD. The historical evolution of thought regarding multiple micronutrient nutrition. J Nutr. 2012;142:143S-156S.
77. Darko S. Compliance and consumer acceptability of multiple fortified stock powder. J Applied Sci. 2010;10:1732-1739.
78. Sauberlich HE. Laboratory tests for the assessment of nutritional status. 2nd ed. Boca Raton, FL: CRC Press; 1999:161-174.
79. Frank GP, Voorend DM, Chamdula A, et al. Pellagra: a non-communicable disease of poverty. Trop Doct. 2012;42:182-184.
80. Kumar R, Kumari S. Evaluation and management of photosensitivity in children. Indian Pediatrics. 2008;45:829-837.
81. Kennedy DO. B Vitamins and the brain: mechanisms, dose and efficacy-a review. Nutrients. 2016;8:68.
82. Böhler A, Moll C, Schaffner A, et al. Alcoholic pellagra encephalopathy: an underestimated treatable entity [in German]. Schweiz Med Wochenschr. 1994;124:720-724.
83. Delgado-Sanchez L, Godkar D, Niranjan S. Pellagra: rekindling of an old flame. Am J Ther. 2008;15:173-175.
84. Ashourian N, Mousdicas N. Images in clinical medicine. Pellagra-like dermatitis. N Engl J Med. 2006;354:1614.
85. Nogueira A, Duarte AF, Magina S, et al. Pellagra associated with esophageal carcinoma and alcoholism. Dermatology Online J. 2009;15:8.
86. Hegyi V. Dermatologic manifestations of pellagra differential diagnoses. February 2016. http://emedicine.medscape.com/ (last accessed 1 September 2017).
87. Hoffman RS, Goldfrank LR. Ethanol-associated metabolic disorders. Emerg Med Clin North Am. 1989;7:943-961.
88. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med. 1983;6:101-197.
89. Saracíbar N, Ferrer I, Arbizu T, et al. Pellagroid encephalopathy in chronic alcoholism: clinicopathological study (author's transl) [in Spanish]. Med Clin (Barc). 1980;75:151-155.
90. Jacobson EL. Niacin deficiency and cancer in women. J Am Coll Nutr. 1993;12:412-416.
91. Jacobson EL, Shieh WM, Huang AC. Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis. Mol Cell Biochem. 1999;193:69-74.
92. Oh GS, Kim HJ, Shen A, et al. New therapeutic concept of NAD redox balance for cisplatin nephrotoxicity. Biomed Res Int. 2016;2016:4048390.
93. Hageman GJ, Stierum RH. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat Res. 2001;475:45-56.
94. US Department of Health and Human Services; US Department of Agriculture. Dietary guidelines for Americans 2010. January 2011. http://www.health.gov/ (last accessed 1 September 2017).
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台